Description
SWOT ANALYSIS OF SANOFI
Sanofi
Parent Company
Sanofi
Category
Pharmaceutical
Sector
Health care
Tagline/ Slogan
Because health matters
A global leader in healthcare and Diversified, Discovers, Develops and USP distributes therapeutic solutions Focused on patients' human needs
STP
Segment
Cardiovascular, CNS, diabetes, thrombosis, oncology
Target Group
Healthcare professionals, doctors & hospitals
Sanofi Aventis is diversifies global healthcare company focused on Positioning patient’s needs
SWOT Analysis
1. It is forth largest company by prescription sales 2. It has over 100,000 well trained employees in 100 countries 3. Its oncology pipeline portfolio has more than 15 molecules in pipeline which are in maturing stage 4.It has acquired US biotech company Genzyme which has given it Strength considerable presence in uncommon diseases
1. Employee layoffs generated lot of negative publicity for company 2. Strong govt rules and regulations increase efficiency and cost of Weakness operations
1. They can merge with other pharma companies in south Africa to increase number of drugs 2. Increasing health awareness 3. They have considerable presence in emerging markets which can be Opportunity leveraged by updating healthcare facilities
Threats
1. Increasing pressure by government to reduce the costs
2. Stringent regulations in new drug development 3. Global economic slowdown
Competition
1. Abbott laboratories 2. Novartis pharmaceuticals 3. Amgen pharmaceuticals Competitors 4. Amicus therapeuticals
doc_369351282.docx
SWOT ANALYSIS OF SANOFI
Sanofi
Parent Company
Sanofi
Category
Pharmaceutical
Sector
Health care
Tagline/ Slogan
Because health matters
A global leader in healthcare and Diversified, Discovers, Develops and USP distributes therapeutic solutions Focused on patients' human needs
STP
Segment
Cardiovascular, CNS, diabetes, thrombosis, oncology
Target Group
Healthcare professionals, doctors & hospitals
Sanofi Aventis is diversifies global healthcare company focused on Positioning patient’s needs
SWOT Analysis
1. It is forth largest company by prescription sales 2. It has over 100,000 well trained employees in 100 countries 3. Its oncology pipeline portfolio has more than 15 molecules in pipeline which are in maturing stage 4.It has acquired US biotech company Genzyme which has given it Strength considerable presence in uncommon diseases
1. Employee layoffs generated lot of negative publicity for company 2. Strong govt rules and regulations increase efficiency and cost of Weakness operations
1. They can merge with other pharma companies in south Africa to increase number of drugs 2. Increasing health awareness 3. They have considerable presence in emerging markets which can be Opportunity leveraged by updating healthcare facilities
Threats
1. Increasing pressure by government to reduce the costs
2. Stringent regulations in new drug development 3. Global economic slowdown
Competition
1. Abbott laboratories 2. Novartis pharmaceuticals 3. Amgen pharmaceuticals Competitors 4. Amicus therapeuticals
doc_369351282.docx